On Friday, Atricure Inc (NASDAQ: ATRC) opened lower -3.68% from the last session, before settling in for the closing price of $34.82. Price fluctuations for ATRC have ranged from $18.94 to $43.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 16.03% annually for the last half of the decade. Company’s average yearly earnings per share was noted 30.06% at the time writing. With a float of $47.13 million, this company’s outstanding shares have now reached $48.87 million.
In an organization with 1300 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 74.37%, operating margin of -8.6%, and the pretax margin is -9.39%.
Atricure Inc (ATRC) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Atricure Inc is 3.58%, while institutional ownership is 96.09%. The most recent insider transaction that took place on Mar 05 ’25, was worth 232,532. In this transaction Director of this company sold 6,100 shares at a rate of $38.12, taking the stock ownership to the 17,828 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Director proposed sale 6,100 for $38.04, making the entire transaction worth $232,044.
Atricure Inc (ATRC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 30.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.66% during the next five years compared to -0.33% drop over the previous five years of trading.
Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators
Check out the current performance indicators for Atricure Inc (ATRC). In the past quarter, the stock posted a quick ratio of 2.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Atricure Inc (ATRC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.54 million. That was inferior than the volume of 0.6 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.14%. Additionally, its Average True Range was 1.59.
During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 38.14%, which indicates a significant increase from 19.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.54% in the past 14 days, which was lower than the 52.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.93, while its 200-day Moving Average is $30.29. However, in the short run, Atricure Inc’s stock first resistance to watch stands at $34.70. Second resistance stands at $35.87. The third major resistance level sits at $36.49. If the price goes on to break the first support level at $32.91, it is likely to go to the next support level at $32.29. The third support level lies at $31.12 if the price breaches the second support level.
Atricure Inc (NASDAQ: ATRC) Key Stats
There are currently 48,880K shares outstanding in the company with a market cap of 1.64 billion. Presently, the company’s annual sales total 465,310 K according to its annual income of -44,700 K. Last quarter, the company’s sales amounted to 124,280 K and its income totaled -15,570 K.
